Kanglin Biotech
Hangzhou
About Kanglin Biotech
Kanglin Biotech is a national high-tech company that create first- and best-in-class revolutionary gene therapies.Kanglin Biopharma specializes in the discovery, development, and commercialization of novel gene therapy treatments for diseases that adversely impair human health, including as thalassemia, AIDS, hemophilia, and Parkinson's disease.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $21.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Sep 2025)
- Website: kanglinbio.com
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/kanglin-biotech-88283 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.